Wednesday, July 2, 2025
Home Blog Page 17

Social Media Tips Every Startup Should Use

0

As a startup business, one has to assume you have very little money for marketing. If you do have a lot of money for marketing, then don’t spend it on social media promotion. The advertising platforms on social media were built to drain your funds as efficiently as possible.

Even if you have money, use it conservatively, and follow the advice in this article when it comes to social media marketing.

Test Trends But Do It Sparingly

You want to build a little bit of influence quickly, so you test out a few trends. If you are going to trend-route, then try them out during the outbreak and check your response rate. If things go well, then leave the content up there. Then again, if your content doesn’t pop in the way it should, then simply delete it and try it on a different platform.

Test trends sparingly because they can undermine your brand and make you look foolish. For example, at the time, the ice bucket challenge was a big deal. However, there are now men and women trying to run for political office who are having trouble gaining credibility because of videos of them having ice poured over their heads.

Mass Media Saturation

When you create a good piece of social media content, you should share it on all of your social media platforms and across all of your accounts. This will mean you have to tinker with your posts to make them fit. For example, the resolution for a TikTok video, along with the music and timing, is going to differ from that of a regular YouTube video. The only time you shouldn’t post your content across every social media platform is when you are testing out a trend. This is because trends don’t always transfer across platforms. For example, your SpongeBob uniform content may not do very well on your Reddit pages but may do great as a YouTube short.

Buying Your Pre-Baked Audience

You want to gather a bit of attention and a bit of a following, but you don’t want to use trickery like click farms. Unless you are willing to spend thousands on a marketing platform, you are going to have to find followers another way. One way is to buy the social media account of another person, and then promote your content to those people. You can go to a website like Fame Swap and buy some attention from other people.

For example, let’s say you run a small business selling baby clothes. Your social media accounts are full of baby-clothing reviews. You go to Fame Swap, and you see somebody who has a big social media following because they offer baby and toddler parenting advice. You buy that person’s social media account and promote your content while safe in the knowledge that the people you are marketing to are already interested in content related to babies.

Avoiding Click-Farms Except Under This One Circumstance

You probably shouldn’t use a click farm. They will give you likes and follows, but they don’t have a very big effect on your search engine and social media ranking. Even if you buy one million views for your post, it still won’t reach the first page of the social media platform. 

The only time you should buy clicks, likes, follows, subscribers, etc., is for social proof. If you have a brand new social media account, and you are offering content on a certain subject. Your content seems better in the eyes of the viewers if you have 4000 followers instead of just 50. Again, buying followers and such won’t make your profile more popular, but it will help build trust between your account and your viewers/visitors.

Image by Gerd Altmann on Pixabay

Author Amelia Williams 

Statements of the author and the interviewee do not necessarily represent the editors and the publisher opinion again.

Where to Find Wholesale Christmas Sweaters for Your Store or Boutique

0

There are plenty of places to find europes leading christmas sweater wholesale brand for your store or boutique, but only one has sustainable and affordable products fit for everyone. Chrismtassweats is a Danish brand that started off in 2016 by two best friends Christoffer Sloth and Jesper Ahm, and only two years later they went full time. The tradition of cute Christmas sweaters that has taken over Europe has never been more appealing.

How to Find the Best Christmas Sweater Wholesale Specialist

When looking for the best europe’s leading christmas sweater wholesale brand, the answer is coming on its own. Christmassweats from Denmark is a Wholesale christmas sweater brand that has taken over the Europe very fast, thanks to their effort and commitment. Honestly, they are the best choice you can get. Their reputation has proven to be excellent, since they are working with 400 resellers already. Now lets see why is this christmas sweater brand perfect for Wholesale across europe

Christmassweats is offering a wide range of sweaters that are able to fit everybody’s style. They can customize on your order, providing they don’t have what you are looking for already. They literally have something for everyone – every color, size, and pattern you can think of. Goofy, fun, for gamers, movie lovers, with LED lights. Apart from Christmas sweaters that made them famous, they can also provide you with other cozy apparel, like pajamas and accessories.

Finally, what makes this brand unique is their sustainability. Their products, and even labels are made all from sustainable and environmentally friendly materials, which is very important in today’s world of fashion.

The benefits of working with a Christmas sweater wholesale specialist

There are many benefits to working with a Christmas sweater wholesale specialist. One of the biggest benefits is that you will be able to get a wide variety of sweaters for an affordable price and be sure that you got excellent quality. Another benefit is that you will be able to find a wide variety of styles and designs, which means that each and every one of your customers will be able to find the perfect sweater for their loved one. Christmassweats can even provide you with various family designs. Finally, working with a Christmas sweater wholesale specialist can also help you save time and money by allowing you to order in bulk.

How to Get the Most Out of Your Christmas Sweater Order

When ordering your Christmas sweaters, be sure to take into account the following:

1. The size – you should really have them all, for men, women, children.
2. The style – think about what your patrons might like, whether it is dog themed sweaters, LOTR themed or sweaters with light.
3. The color – Christmassweats has sweaters of any color, so feel free to go festive over your order.
4. The material – you don’t have to worry about that since Christmassweats is sustainable and environmentally friendly.

Tips for Choosing the Perfect Christmas Sweater for Your Store

There are a few things to keep in mind when choosing the perfect Christmas sweater for your store. First, consider the overall style of your store. Is it more traditional or contemporary? This will help you narrow down your choices and find a sweater that fits with your store’s aesthetic. Second, think about who your target audience is. What age group are you trying to reach? What gender? What interests do they have? Knowing this will help you find a sweater that appeals to them. Finally, consider your budget. How much can you afford to spend on each sweater? With these factors in mind, you are set to make a perfect Chrismtas sweater order.

To sum up, try to find a reliable supplier that can provide you with high-quality sweaters at a reasonable price.

Image by Malachi Witt on Pixabay

Author Bazoom

Statements of the author and the interviewee do not necessarily represent the editors and the publisher opinion again.

Steve Wozniak: Visionary and Co-Founder of Apple

0

Apple is a world-renowned technology company that has consistently been at the forefront of innovation for decades. With a market value of around $2 trillion, it is currently one of the most valuable companies in the world.

Founded by Steve Jobs and Steve Wozniak in the 1970s, Apple has played a significant role in shaping the personal computer industry and has continued to evolve with the changing market. The company specializes in the design, development, and sale of a wide range of products, including smartphones, tablets, computers, and online services. Apple’s products are known for their sleek design, advanced functionality, and user-friendly interface, making them a top choice for consumers around the globe.

Apple and FAANG

Apple has been a driving force in the technology industry since its founding in 1976, introducing innovative products and services that have transformed the way we live and interact with technology. One notable example is the iPod, launched in 2001, which revolutionized portable music listening. Another example is the iPhone, launched in 2007, which marked the end of an era for phones with physical keyboards.

Over the years, Apple’s consistently strong sales and impressive stock performance have earned it a place among the FAANG companies (Facebook, Apple, Amazon, Netflix, and Google), which are among the top-performing tech firms in the United States. Among these companies, Apple has consistently demonstrated strong performance and is often viewed as a solid investment option for long-term investors. 

Even in difficult market conditions, Apple has proven to be a reliable choice for investors, as demonstrated in 2022 when META (Facebook) saw its stock price drop 65% year-to-date while Apple’s stock was only down 25% over the same period.

FAANG Stocks Performance in 2022:

In 2022, the FAANG stocks all faced significant declines in their stock prices:

  • Facebook (META): -65%
  • Apple: -25%
  • Amazon: -49%
  • Netflix: -50%
  • Google (Alphabet): -38%

mong these companies, Apple was one of the better performers, with its stock price ‘only’ down 25% year-to-date. Apple was able to weather the market storm in 2022 better than its peers in the FAANG group. This could be due to a variety of factors, such as the company’s financial performance, market conditions, and investor sentiment.

But how did everything start? Founded by two geniuses in 1976, Steve Jobs and Steve Wozniak, Apple took the world by storm by launching the Apple I in the same year. It was invented and designed by Wozniak, and became the first personal computer.

Steve Wozniak and its Innovations

Steve Wozniak, an American computer engineer, is credited with the invention of the first personal computer and the Apple II series, which was one of the best-selling personal computers of the early 1980s.

Woz (Wozniak’s nickname) has become one of the top entrepreneurship speakers in the world. He often speaks at tech and entrepreneurship events, sharing his experiences co-founding Apple with Steve Jobs and launching the company’s early products. Wozniak also discusses his time working with the innovative and brilliant Steve Jobs.

Wozniak as a Speaker

Booking Steve Wozniak as a speaker for an event is an exciting opportunity for attendees to hear firsthand from a legendary entrepreneur and technology pioneer. As a co-founder of Apple, Wozniak played a crucial role in shaping the personal computer industry and has a wealth of knowledge and experience to share with audiences.

In his moderated discussions, Wozniak often speaks about his experiences co-founding Apple and launching the company’s early products, as well as his time working with Steve Jobs. He also shares insights on entrepreneurship, innovation, and the tech industry, offering valuable advice and inspiration for attendees. It is worth noting that Wozniak does not typically give standalone keynote speeches, but rather participates in moderated discussions or panel discussions.

Having the opportunity to bring Steve Wozniak to an event as a speaker can have a major “wow” factor for attendees. Not only is he a highly respected and influential figure in the tech industry, but he is also a highly engaging and entertaining speaker who can provide valuable insights and inspiration to attendees. 

Semi open apple laptop, macbook air on gray background. Source: Picture from Maxim Hopman on unsplash

Author: David Williams

Statements of the author and the interviewee do not necessarily represent the editors and the publisher opinion again.

The Food of the Future: The Cultured Tilapia of the Israeli Startup

0

The fear of a global food crisis has catapulted the cultured meat market to the size of billions dollars a year. An Israeli company called “E-FISHient Protein” assembled a commando team of experts to achieve as quickly as possible the ability to produce cultured fish on a commercial scale

The need for alternative quality protein sources has turned the cultured meat industry into a market that generates billions. Those who stand out in the field are the Israeli foodtech companies, among them the “BioMeat FoodTech” company, which invests in the field of cultured meat and meat substitutes. Following its commercial success, the company announced the establishment of E-FISHient Protein, a joint startup with the Volcani Institute. The startup will carry out development, production and marketing of cultured fish meat based on non-animal serum.

The company will be led by the E-FISHient’s CEO Dana Levin, BioMeat’s CEO  Gilles Gamon, and its product development will be based on a scientific team headed by Dr Yaakov (Kobi) Biran, specializing in genome editing and neuroendocrine regulation of stress and metabolism in edible fish, with an emphasis on tilapia.

E-FISHient’s R&D creates a technological knowledge base focused on the isolation of cells with the potential to differentiate into muscle cells and long-term storage which will be used as DNA bank (cell line).

The company will direct its activities to turn the acquired knowledge into an effective basis for growing cultured tilapia meat on a commercial scale, with the aim of expanding to cultured meat of other kinds of fish and expanding the range of products that can be developed.

E-FISHient will also undertake the development of an artificial serum that may become a related commercial product of great significance for the cultured meat industry.

How do the fish get to our plate these days?

A population of 3.3 billion people in the world currently eats fish and other seafood, which make up 20% of their protein sources in the Western world (in some parts of the world fish make up to 50% of the daily protein intake). Today most of our fish comes from the fishing industry or aquaculture.

These two sources of industry, marine fishing and fishponds, are in a problematic situation: already today, more than 80% of the world’s fishing areas are used to the limit of the oceans’ ability to renew themselves at a high enough rate to keep up with the fishing. Besides, in a large part of the world’s fishing grounds there is a massive reduction in fish yield as a result of the destruction of the marine ecosystem that produces the marine food.

Even the fish that reach the net, whether by fishing or in the fishponds, are found to be full of parasites, diseases and microplastics.

Furthermore, in the fishponds, the result is a lack of edible fish. Significant contaminations were discovered in the fish farm products. In the US, the FDA has issued a specific warning about tilapia aquaculture, due to it being a source of parasites, chemicals and a host of diseases.

What’s the solution? Cultured tilapia fish fillet

The world already understands that if we do not reach alternative solutions for available protein sources, we are at the threshold of a global food crisis that will affect the entire world’s population.

E-FISHient CEO Dana Levin says: “I am proud to have the opportunity to lead E-FISHient towards becoming a global player at the forefront of innovation in the field of cultured fish production. The enormous ecological damage from the fishing industry together with the expected increase in the world’s population, call for an urgent solution that will provide clean, healthy, nutritious, ecological and high-quality fish meat for us and for the planet. I am happy to promote a futuristic and groundbreaking product. With the help of top-notch research and a commando team of experts, we aim to bring a new message to the world with regard to the fish we humans consume”.

Just last month, the American FDA first approved UPSIDE Foods company’s cultured meat as safe for consumption. This is also a significant step for the E-FISHient, which is targeting the American market, both in terms of the market scope and of the regulatory approval. “Our ambition is to produce cheap, high-quality and delicious fish that will be available to the masses, sums up Levin.

Picture: photo credit: E-FISHient PR

Source E-FISHient Protein

Always keep learning new things

0

Juniper Biologics innovative medical treatments in the areas of oncology and oncology supportive care, rare/orphan diseases, and gene therapy

Please introduce yourself and your startup Juniper Biologics to our readers!

I am Raman Singh, founder and CEO of Juniper Biologics, a science-led specialty healthcare company focused on commercialising novel therapies. And I have had a long career in the healthcare industry spanning over 20 years with management roles at Mundipharma, AbbVie and GSK. 

I founded Juniper Biologics in 2021 in Singapore and since then, we have been expanding rapidly across the globe. Outlined by our ESG values, our mission is to make a real impact on the lives of patients while increasing accessibility to the next generation of treatments. We bring innovative medical treatments to patients in the areas of oncology and oncology supportive care, rare/orphan diseases, and gene therapy.

How did you get the idea of Juniper Biologics?

Having worked in various regions and seeing the positive impact of my actions in the healthcare industry inspired me to launch Juniper Biologics. I saw first-hand the healthcare inequality in certain regions where access to essential medicines was a challenge, or where the needs of patients suffering from a rare disease were unmet. It is not uncommon for big pharma companies to focus on treatments for the multi-millions, rather than the hundreds or thousands of patients suffering from a rare disease.

It was also clear to me that there were no innovative research and development-driven healthcare/biotech companies in Asia, the Middle East, and ANZ (the emerging markets) – either companies are domesticated in China, Korea or Japan, or big pharma companies have a foothold in the emerging markets. I identified this gap in the market and knew I needed to build a pharma company that focused single-mindedly on helping the patients in those regions. I knew that this is where Juniper Biologics would have a profound impact, because everyone deserves access to treatments that improve the quality of their life. 

Why did you decide to start with Juniper Biologics?

During the COVID-19 pandemic, I spearheaded research and development efforts to investigate how we as an industry could combat the accelerated spread of the virus. Laboratory tests with Duke-NUS and other labs were initiated to prove that certain Betadine products could kill the COVID-19 virus in 15 and 30 seconds. Seeing the extent that my work had on people’s health on a global level compelled me to start Juniper Biologics. I began by searching for innovative medicines that would improve the quality of life of patients suffering from debilitating illnesses such as cancer. I wanted to start an ESG-focused company that would always be committed to putting the patients and their needs first and to providing treatments for areas that are often overlooked or ignored.

What is the vision behind Juniper Biologics?

Since Juniper Biologics launched in 2021, it has hit several milestones. One such milestone is the conclusion of an up to USD$600 million acquisition for the licensing rights to develop and commercialise TG-C LD, the world’s first cell-mediated gene therapy for the treatment of knee osteoarthritis. We plan to make this treatment available to an estimated 300 million patients in Asia Pacific, the Middle East, and Africa. 

In the last 12 months, we have inked six licensing agreements, and added Aloxi, Akynzeo and Anamorelin to our oncology supportive care portfolio, an area that has a strong unmet need globally. Strongly in line with our ESG-based mission to improve affordability and accessibility, my vision for Juniper Biologics is to continue to expand our portfolio and focus on areas where we can make a difference and bring our treatments to people in all corners of the globe.

How difficult was the start and which challenges did you have to overcome?

As a young company with a big ambition, one key task was to assemble a team with a DNA of never giving up, a rallying cry that defines us. Since 2021, the company has grown at an exciting rate with now close to 100 employees in over 10 offices across Asia, Oceania, the Middle East and Africa. 

The acquisition process began in mid-2021, with identifying the right medicines to satisfy the unmet needs of patients and the right partners from which to license these products. I knew that to acquire next-generation medicines in oncology, rare diseases and gene therapy, we would need strong backers. That is how the Sylvan Group, an investment company that focuses heavily on ESG and supporting businesses that have a positive value for society and the environment, came on board. Aligning very closely with my personal ESG values, the Sylvan Group were the first to back Juniper Biologics. This was just the beginning – other investors have now become interested in supporting our vision, and we look forward to announcing these soon.

The biggest challenge that we’ve had to overcome is bringing a medicine to market. It is a long process and often takes years of due diligence and approvals from relevant drug regulatory authorities. It poses even more of a challenge when each country has different regulations and systems. We have learned that it is essential to establish communications and partnerships with the local regularity experts who can help us better understand the nuances of the market.

Who is your target audience?

Since we focus on commercialising the medicines and treatments for market distribution, our target audience are both healthcare professionals, as well as influential members of the scientific and healthcare community. We target healthcare professionals who we can work with to distribute the innovative medicines. And we also work with the scientific community to see what novel treatments we can bring to market. We connect with people in these communities by attending events that introduce us to the most relevant networks.

Additionally, we collaborate with other pharma companies, as well as with leading CROs, KOLs, and universities. We also build strong relationships with academicians who are researching and bringing innovative medications to patients in the emerging world. These collaborative relationships aid us continuously looking for the next generation of treatments in our chosen therapy areas.

What is the USP of your startup?

We find and commercialise products that are quite niche and centred on unmet needs. Big pharma companies typically go for the blockbuster products. For instance, while these companies may focus on curing cancer, we deliver products that help people currently suffering from cancer attain a better quality of life. 

We are also focused on the area of gene therapy, particularly TGC, in parts of the world that have growing aging populations. We know that our work will improve their quality of life. The same goes for rare diseases as we look at the unmet needs of patients suffering from diseases that sometimes do not receive the attention they deserve.

The fact that we are a young company also allows us to be agile and nimble on how we look at different products and acquisitions. Because of our size, we can commercialise and distribute these products a lot quicker. It also enables us to minimise the impact of our products and operations on the planet and uphold the sustainability element of our ESG values. 

Can you describe your typical workday?

I start every day with a run. This is an absolute must as it energises me and puts me in the right frame of mind to take on the day. After that, I’m typically plugged into meetings and calls all day, which often continue well into the night. I am also always on the lookout for the next innovative treatment and expansion opportunity that improve accessibility to essential and affordable medicines.

Above all, I make sure to take the time to check in with my teams around the world – they are the backbone of Juniper Biologics and I want to ensure that I am doing all I can to help them succeed. I also want to always be as transparent as possible with my team and update them on all my plans for moving forward with the company. Leading with transparency within the company sets a precedent and standard of transparency for all our work, which keeps us accountable as responsible corporate citizens.

Where do you see yourself and your startup Juniper Biologics in five years?

My priority is looking for the next generation of medicines and expanding access to the treatments we offer. We are currently in advanced negotiations to add to our oncology supportive care portfolio. We also announced the acquisition of Ledaga, a topical gel treatment for people suffering from MF-CTCL, the most common cutaneous T-cell lymphoma for which we secured licensing and marketing authorisation to promote and sell in Australia, Southeast Asia, and the Middle East.

I am also very focused on building our Juniper Biologics team. Recently we opened offices in Korea, the Middle East, Japan and established our global headquarters in Singapore. We will be continuing to open offices in several key markets, allowing us to offer our treatments in many regions.

In the long term, we see ourselves as a leading pharmaceutical company with a global network, breaking down barriers and ensuring accessibility for all those in need.  

What 3 tips would you give to founders?

To be a good founder, and therefore leader, it is important to adjust to what is happening around you. It seems basic but we’ve seen expectations and values needing to evolve, particularly with the pandemic, and traditional leadership methods have been challenged. With new generations joining the workforce, you need to be flexible and be able to manage them differently.  

Next it is important to focus on communication. Master the different communication platforms and be available as well as authentic. Nurture your relationship with your team and listen to their views and their suggestions. 

Finally, always keep learning new things. Read about new market trends, technologies, or new parts of the world. Learn about different cultures and make connections with as many new people as you can. This keeps you up-to-date on what is happening in the world and can inspire you on how to keep your business relevant.

More information you will find here

Thank you Raman Singh for the Interview

Statements of the author and the interviewee do not necessarily represent the editors and the publisher opinion again.

Spike Raises $700K to Help Digital Health Firms Utilize Data from Wearables and IoT Devices

0

The Silicon Valley-based data tech and AI startup has closed a pre-seed funding round to help millions of users worldwide improve their health. 

Spike, makers of the API aggregation and an ETL solution for data from wearables and IoT devices, today announced the closing of a $700,000 pre-seed round to help digital health firms improve their clients’ lives. Spike allows companies to easily integrate biomarker data from 200+ wearable sensors and IoT devices into their applications. The funding round was led by Geek Ventures of New York City, with participation from CEAS Investments and APX.

Data collected from wearable sensors, smartwatches, and IoT devices are actively used throughout the healthcare industry. However, only a fraction of the market participants know how to utilize the data to its potential. Using Spike, businesses can integrate data from commercially used optical, electrical, electrochemical, and electromechanical sensor types via a single API. These devices extract biometric data such as heart rate variability (HRV), glucose and cortisol levels, calories, sleep depth, blood pressure, and more. Spike imports these metrics directly into clients’ cloud via a managed ETL service while providing AI tools for health-related prediction, recommendation, and prevention. 

“Wearable sensors are becoming much smaller, more accurate, and accessible to a broader user base. Our solution helps digital health companies easily integrate biosensor data, process it, and apply AI models. Developing this tech in-house is complicated, expensive, and resource-heavy. Spike aims to make this data management journey effortless and open opportunities to the next-generation of healthcare and disease prevention,” said Povilas Gudzius, co-founder and CEO.

Spike’s pre-seed funding round was led by Geek Ventures in NYC, with participation from Florida-based CEAS Investments and APX, an early-stage investor based in Berlin and backed by Axel Springer and Porsche. Angel investors from Austin, Texas, NYC and Silicon Valley also participated in the round. “Receiving backing from these experts is a vote of confidence for our team and further solidifies our mission, to bring benefits of cross-sensor data fusion to real-life challenges such as improving health”, said Povilas Gudzius.

It is estimated that over the next eight years, a person, on average, will use up to 30 different IoT devices – three times more than we use now. The growth in wearable sensors and biomarker data has resulted in hundreds of new applications for professional fitness, diabetes prevention, nutrition, cardiovascular health, mental health, longevity, and others. The data we generate will only increase, and businesses need to leverage it accordingly. Spike is built to gather and analyze this type of data securely and effectively.

Source FAKTOR 3 AG

How to write a startup press release that gets noticed

0
How to write a startup press release that gets noticed

If you want the media to notice your startup, you will need to write a press release. This document is a simple way for you to tell the world your story, and it can help you generate publicity and attract new customers. Learn some useful tips for writing a press release that will get you noticed.

According to statistics, approximately 305 million startups are launched globally every year but not all of them succeed in tough competitive market conditions. This is where a press release comes in handy. It contributes to building a more complete picture of the company and its products and informing the public about the most recent announcements. If you want a cheap essay or material for a press release that you find hard to produce, seek assistance from writing services professionals.

How do you write a press release that gets the media’s attention?

Here are some pointers on how to write a startup press release that will help your brand get noticed:

1. The key components of a successful startup press release

A successful press release should have:

  • A well-written headline;
  • Key facts and figures;
  • Company overview;
  • Product description and images.
2. Write an attention-grabbing headline

A good headline will grab the reader’s attention and ensure that they click through to read your content. Be descriptive and use keyword-rich headlines that accurately reflect the content of your press release. Keywords can help attract interested readers from all over the web, which could then lead to increased traffic for your website or product. For example: “New Product Launches to Spark Innovation and Progress.”

3. Write effective paragraphs

Start your paragraphs with a hook, something that will pique the reader’s interest and draw them in to read more. Subsequent paragraphs should focus on providing valuable information that journalists can use to inform their readership. For example:

  • The title: A headline for your release that summarizes the main points;
  • First paragraph. The opening paragraph introduces the news and provides a brief overview;
  • Second paragraph. It contains additional information about the release, including quotes or images if applicable;
  • Third paragraph. A quote from your CEO or a business co-founder, followed by a closing sentence or paragraph;
  • Fourth paragraph. Bring in trends to explain why this announcement is relevant;
  • Fifth paragraph. Wrap up with a brief sentence or two summarizing the main points of your announcement;
  • Sixth paragraph. An invitation to journalists to contact you for more information.
4. Use active verbs

Whenever possible, use active verbs to emphasize the actions or results of your new launch. For example, describe how customers can benefit from using your product or service, rather than simply telling them about it.

5. Avoid jargon

If you are going to use technical terms in a press release, be sure to explain them to journalists before doing so. Otherwise, they may have difficulty understanding what you are saying and could make incorrect assumptions about the significance of your announcement.

6. Make sure your content is easy to read and understand

Your target audience should be able to get the most out of your content without difficulty. Use simple language with clear grammar so that readers can follow what you are saying easily.

7. Consider using images

Images are a great way to illustrate your points and can help attract attention from potential customers and journalists alike. Make sure you have high-quality images that accurately reflect the product or company being highlighted in your press release.

8. Always cite sources when using quotes

Journalists always require attribution for the content they publish. So, make sure to include sources for all quotes and images in your release to ensure your information is accurately represented.

9. Proofread your release carefully

Mistakes happen, so make sure to check for typos and grammar mistakes before hitting “send.”

What should be the length of the startup press release?

Press releases should be no more than 400-500 words in length.

Conclusion

Writing a press release is an essential part of any startup’s marketing plan. It will get your company noticed no matter where you are in your startup journey. Whether you are only starting, or have been releasing press releases for a while, the tips highlighted above will help you write a successful press release that will help your business grow.

Image by drobotdean on Freepik

Autor: Frank Hamilton

More articles from Frank Hamilton you can find here

Frank Hamilton is a blogger and translator from Manchester. He is a professional writing expert in such topics as blogging, digital marketing and self-education. He also loves traveling and speaks Spanish, French, German and English.

Statements of the author and the interviewee do not necessarily represent the editors and the publisher opinion again.

secjur, the Digital Compliance Office for businesses, has announced its seed funding round

0

secjur raises €5.5 million in seed funding from Visionaries Club and other investors to revolutionize compliance process automation 

Hamburg-based startup secjur has developed the “Digital Compliance Office”, an AI-based compliance automation platform. After initially bootstrapping the development to market launch, the team has now announced the closing of a €5.5 million seed round. The round is led by Visionaries Club accompanied by Mario Götze, Nico Rosberg and other business angels. 

secjur automates processes in the Digital Compliance Office that are related to fields such as data protection, information security, anti-money laundering and whistleblowing. Using their tool, companies can solve compliance challenges at the speed of light. secjur plans to become the world’s leading provider in the relatively new sector of compliance automation. The product is already the market leader when it comes to data protection and information security in Europe.

The founding team, consisting of Niklas Hanitsch, Manuel Stahl, Simon Pentzien and Sven Moritz, was already very successful with secjur within the first few years: partnerships and customer relationships were established, e.g. with Mercedes Benz, Samsung, Yunex Traffic, 1KOMMA5°, MediaMarkt Saturn, Pantaflix, Klitschko Ventures and Tomorrow Bank. Over the past years, the team has grown to almost fifty employees. In addition, secjur and its Digital Compliance Office won first place in the German Startup Cup in the cybersecurity category. 

Co-Founder Niklas Hanitsch says:

“Compliance is as versatile as it is complex. Not only data protection requirements are becoming more and more extensive, but compliance in all kinds of areas. For example, many companies are required to implement an information security management system. In the coming years, many other compliance challenges will add to this, such as AI regulation. Regulation can help in protecting consumer rights and make both the digital and the real world a better place. Nevertheless, implementing compliance is very demanding and poses major challenges for companies. That’s where we jump in and support with our smart solution. ” 

Robert Lacher from lead investor Visionaries Club sees substantial added value for companies in the automation of compliance and thus almost limitless potential for secjur:

“Sadly, compliance has become a massive pain for businesses of all sizes since its management is manual, repetitive and expensive. secjur solves this by automating compliance for businesses of all sizes and allows them to manage it within one software. In the future, they will be part of every company’s IT stack.”

The collected capital is to serve the further development of the AI-based platform as well as the expansion within the DACH region and other markets.

Picture Founder Team (from left to right_ Niklas Hanitsch, Manuel Stahl, Simon Pentzien, Sven Moritz) ©NONA STUDIOS

Source COHORT GmbH

Thinking Outside the Field: Plant Nutrients—Without the Plant

0

Nutri-tech start-up Novella leverages advanced technology to grow botanical ingredients outside the field.

Nutri-tech start-up Novella, Ltd., is opening a new chapter in climate-resilient environments through nutrient cultivation. The company leveraged proprietary technology to grow nutritious botanical ingredients while leaving the whole plant out of the equation. This novel platform in the plant world will help boost global accessibility to high-value nutraceuticals. 

Addressing the growing demand for botanical micronutrients, the new technology overcomes supply chain disruptions, circumvents climate change, and expands plant life cycles. 

“We don’t need the whole plant to get access to specific bioactive compounds,” explains Kobi Avidan, CEO and co-founder of Novella. “It also isn’t necessary to discard up to 99% of a plant and incur tons of agricultural waste just to derive specific nutrients. We have the technology where we can narrow the harvest of an entire field for its plant essence in a single bioreactor.”

Field-to-bottle fails

The traditional “field to bottle” protocol for producing nutraceuticals involves a long, complex, and often vexing process of lengthy cultivation and labor-intensive harvesting of sensitive botanicals, and the use of vast stretches of agricultural land. Then, the raw materials must be transferred—often overseas—to a factory for extraction before transfer to another factory, often in yet another country, for formulation into a final supplement. This can also lead to difficulties in achieving standardized doses of the natural substances.

The supply chain for botanical extracts is continuously at the mercy of the natural growth cycles of the plants, volatile environmental conditions, climate fluctuations, and social and economic constraints. These have been further compounded by recent political instabilities and logistical hurdles which have yet to recover from the pandemic era.

All of these setbacks hit the nutraceutical business at a time when it is experiencing its greatest boom ever, attaining a global value of billions of US dollars. This has put further immense strain on industry to meet demand, as well as on the planet’s finite resources.

Thinking outside the field

Rather than grow the whole plant, Novella screens specific plant tissues—including stems, fruit, leaves, and flowers—to determine the highest concentrations of desired actives. A cell culture (callus) is formed from these tissues and amplified in bioreactors. This results in a pure, pesticide-free powdered product composed of whole-cell plant tissues with their naturally occurring complex of nutrients intact.

Novella’s cultivation system eliminates the need for extraction by increasing the concentration of the actives within the plant cells themselves, which are contained in a natural protective shell to prevent oxidation. This also assures full bioavailability.

“Growing nutrients outside the plant is actually a simpler process than growing meat cells outside of the cow,” explains Avidan “Moreover, we can now cultivate any ingredient close to the market of interest. This will be instrumental in lowering costs, as well as lightening their ecological footprint.”

The start-up will grow the ingredients in a controlled, strictly non-GMO environment, with precise regulation of stressors such as light and temperature in order to create an ideal environment for cultivation of specific bioactives at consistently potent and highly precise quantities. 

Novella has made headway in exploring certain vegetables, such as kale, for sourcing some popular in demand vitamins and antioxidants. Although hailed as a nutrient-dense “super plant,” many consumers avoid kale due to its bitter flavor and tough, fibrous texture.

“Kale has captured the interest of the functional food, supplement, and pharma industries due to its long list of vitamins and minerals,” asserts Shimrit Bar-El, PhD, co-founder and CRO of Novella. “But it is very difficult to work with and process. We are specifically exploring the vegetable for its vitamin K and unique carotenoid composition.”

Novella can grow any type of plant tissue but currently is focusing on the cultivation of a few high-end botanicals, including some widely consumed vegetables that boast potent concentrations of nutrients such as vitamin C that cannot be extracted via existing methods. 

“Consumers continue to demand products that are microbiologically safe, natural, and without chemical additives,” explains Itay Dana, B.Sc., MBA, co-founder and BDO for Novella. “There is an increasing demand for natural botanicals, accompanied by incremental rises in prices resulting from a shortage of such products.”

“By shifting the cultivation of popular micronutrients to the lab, the Novella platform can help free up extensive agricultural terrain for rededication to the growth of food crops while making high-value nutraceutical ingredients more readily available at affordable prices,” concludes Dana.

Source NutriPR

Believe in your idea

0

YesColours: Feelgood paints in astonishing colours

Please introduce yourself and your startup YesColours to our readers!

J&E: Hi! We are John and Emma, co-founders of the eco-conscious homegrown paint brand, YesColours.

Targeted at the new generation of home improvers, we have created Europe’s first fully recyclable pouch which aims to cut consumer waste and stop paint tins from going straight to landfill.

It’s not just our revolutionary packaging that makes us stand out from the crowd. We are turning the industry on its head to reinvent what it means to be a truly eco-friendly company. Our recyclable pouches start from 1litre, helping to avoid over-ordering at the point of purchase – one the main reasons for the waste generated in the UK. 

Customers can breathe easy knowing we’ve left out any harmful chemicals such as VOCs, APEs, NPEs and microplastics. These important details mean our paint is completely safe for you, your family, your pets and the environment. 

YesColours is more than just paint, we’ve carefully curated a palette using colour theory to support wellbeing through a collection of feel-good shades, whether Joyful or Serene, Friendly or Electric.

Putting people and the planet first is truly at the forefront of every decision we make. We recognise that we need to do our part at making a difference, which is why you’ll spot YesColours in the likes of Sheffield Children’s Hospital. We’ve also partnered with numerous community spaces and mental health charities such as Place2be, Rethink, MindOut as well as NIP cancer recovery.

How did you get the idea of YesColours?

J&E: The initial idea was based around finding a solution to a common problem: trying to recycle paint tins. Currently, only 2% of paint waste gets recycled, with over 55 million litres of paint and 14,000 tonnes of tins going to landfill every year. We put our design experience into action and innovated a completely new type of packaging, one that can be recycled in the home and save time and waste for our customers, cutting out waste at the point of purchase.

We were inspired to create a paint brand that changes the way we decorate for the better, without compromising on colour.

Why did you decide to start with YesColours?

J&E:  The way design can impact how we live has always been fascinating to us. Coming from the branding, product and digital design world —the intersection of how we live, work and travel and how design can impact all of these is astonishing. Creating a space which can improve your mental health, make you feel safe, relaxed or uplifted has never been more important.

So, when considering the home, our most valuable space, it’s important to choose materials, colours and products wisely to create a space that is not only liveable but enables you to live better.

YesColours, is the embodiment of these principles to make sure that if a customer chooses our products, they are doing so with their wellness, but also their creativity in-mind — we want to liberate home decor from the traditional approaches.

What is the vision behind YesColours?

J&E: In terms of the business strategy, this has evolved from a singular vision of how to tackle an environmental problem, to broader considerations around products and initiatives that we feel will have a benefit to our communities. Our considerations are now not only just DTC, but larger commercial projects and opportunities as well as brand partnerships.

We keep sustainability at the heart of how we operate, from our packaging to our supply chains, to our use of raw materials and supporting UK manufacturers. YesColours is Made in Britain accredited.

How difficult was the start and which challenges you had to overcome?

J&E: Supply chain management has most definitely been our biggest obstacle. Starting a business during unprecedented times has been a huge challenge, as it has for many others out there. 

However, without lockdown, we certainly wouldn’t be where we are. It’s enabled us to take the time required to get our brand, our values and our product exactly how we envisaged. 

After 20 years of friendship, having open communication every day is key to overcoming challenges. There are more joyous than difficult days. Humour is key and we’ve got that in bucketloads!

Who is your target audience?

J&E: Homeowners, renters and creatives. We aim to inspire a generation to rediscover their connection to colour with palettes that allow them to unlock their creative edge while being kind to the planet. 

What is the USP of your startup?

J&E: To inspire joy and optimism through feel-good paints in astonishing colours.

Our brand promise is the result of two passions and one commitment, which together are the beating heart of YesColours. First—we love colour. Second—we want to make people feel good, to inspire optimism and hope. Third—we’re committed to sustainability. Together, they establish a set of guidelines that bring our brand to life wherever and however our audiences interact with us. They define all that we do.

Can you describe your typical workday?

J&E: We go through our company’s email first and catch up with queries and orders, then look at our own emails for the day ahead. I’m (Emma) usually working on some form of colour content whether that’s mood boards for clients, creating colour reports or developing colours for new seasons.

There’s always a community project going on too, usually with one of the mental health charities we love to partner with such as Place2Be. 

We’re in an industry that’s going through some exciting changes and we like to think that we’re part of that. Working with such a creative community with a product that is inherently creative and diverse, gives so much room for exciting things to happen.   

The day will always start with a message first thing in the morning, often comical or something to give the other a boost. But so far, there’s never really a typical day! 

Where do you see yourself and your startup YesColours in five years?

J&E: Our mission is to create a future that nurtures creativity and celebrates different cultures to the benefit of our communities, and the world around us.  

Our ambition is also to grow YesColours beyond paints into other verticals — from homeware products to fabrics, to creative pop-ups and community spaces.

We’ll be expanding our product range, developing more innovative paints and packaging, and expanding our team. 

We have excitedly just launched our crowdfunding campaign with Seedrs, which will help us to make our ambitions a reality. 

What 3 tips would you give to founders?

Believe in your idea and always keep hold of that drive and passion which sparked the initial idea. 

Surround yourself with people who share your vision and can offer the skills and advice to help make your idea a reality

And be a nice human… That part really, really matters.

More information you will find here

Thank you John Stubbs and Emma Bestley for the Interview

Statements of the author and the interviewee do not necessarily represent the editors and the publisher opinion again.

LATEST NEWS